While typically supportive of President Donald Trump and his political agenda, on Wednesday, the conservative National Review published a scathing takedown of hisWhile typically supportive of President Donald Trump and his political agenda, on Wednesday, the conservative National Review published a scathing takedown of his

Conservative National Review tears into Trump for being 'softie pushover'

2026/03/18 23:33
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

While typically supportive of President Donald Trump and his political agenda, on Wednesday, the conservative National Review published a scathing takedown of his recent capitulation to Russian President Vladimir Putin on Iran, tarring him as a "softie pushover."

In the weeks since the start of the U.S. and Israel's joint military operations, reports have emerged revealing that Russia is quietly providing aid to Iran behind the scenes. According to a new report from the Wall Street Journal, "Russia has been... providing satellite imagery and improved drone technology to aid Tehran’s targeting of U.S. forces in the region," all in the name of aiding one of its key Middle Eastern allies and prolonging a conflict that helps it "militarily and economically."

Fitting his long-held pattern of treating Putin favorably, Trump has been hesitant to condemn this conduct from Russia, despite the fact that it is endangering the lives of U.S. service members. In his piece for the National Review, conservative commentator Jim Geraghty highlighted Trump's response to the issue when pressed about it on Friday by Fox News's Brian Kilmeade.

"I think [Putin] might be helping [Iran] a little bit, yeah, I guess. And he probably thinks we’re helping Ukraine. Right?" Trump said. "And so, he says that. And China would say the same thing. You know? It’s like, uh, hey, they do it and we do it in all fairness. They do it and we do it."

"That is not exactly a forceful denunciation of Russian assistance to a country currently firing missiles and drones at the armed forces of the United States as well as civilians, nor was there any warning or message to the Russians to knock it off or face consequences," Geraghty wrote.

Geraghty further highlighted some of Trump's other recent reactions to other situations, much less severe than the conflict in Iran, in which the president's words were much harsher. In a Truth Social post from Sunday, he attacked "the absolutely terrible" Federal Reserve Chair Jerome Powell, calling for him "to be investigated for the horrible job he does." In another post, he attacked reporter Maggie Haberman as a "SLEAZEBAG writer for The Failing New York Times, [who] insists on writing false stories about me," despite the fact that, as Geraghty noted, he continues to give her exclusive interviews.

"How much is President Trump willing to forgive Putin? He’s helping the Iranians attempt to kill Americans, and Trump doesn’t seem all that bothered by it. It’s not even worth some harsh words," Geraghty wrote further. "But no matter what Putin does, Trump never seems to get all that angry about him."

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.493
$3.493$3.493
+1.57%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26